These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2333039

  • 1. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May 18; 32(818):49-50. PubMed ID: 2333039
    [No Abstract] [Full Text] [Related]

  • 2. [Adjuvant therapy in breast cancer].
    Semiglazov VF.
    Vopr Onkol; 2000 May 18; 46(1):18-27. PubMed ID: 10789218
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant systemic therapy of breast cancer.
    Lippman ME.
    Important Adv Oncol; 1985 May 18; ():254-72. PubMed ID: 3916744
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Adjuvant therapy in breast carcinoma. A specific immunologic preliminary contribution].
    Fazio M, Calabrese F, Giacomasso S, Mastromatteo V, Negri L.
    Minerva Chir; 1988 Sep 30; 43(18 Suppl):59-62. PubMed ID: 3226597
    [No Abstract] [Full Text] [Related]

  • 8. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
    Rosso R, Boccardo F, Brema F, Sertoli MR, Amoroso D, Bertelli G, Pronzato P.
    Anticancer Res; 1989 Sep 30; 9(4):1153-6. PubMed ID: 2817796
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
    Zielinski CC, Kuzmits R, Kubista E, Salzer H, Staffen A, Aiginger P, Spona J.
    Wien Klin Wochenschr; 1985 May 24; 97(11):493-7. PubMed ID: 4013343
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endocrine therapy for early breast cancer.
    Hussain SA, Williams S, Stevens A, Rea DW.
    Expert Rev Anticancer Ther; 2004 Oct 24; 4(5):877-88. PubMed ID: 15485321
    [Abstract] [Full Text] [Related]

  • 14. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 24; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of breast cancer with hormones and drugs.
    Lippman ME.
    Hosp Pract (Off Ed); 1986 May 15; 21(5):119-27, 131. PubMed ID: 3009506
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    Davidson NE, O'Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD.
    J Clin Oncol; 2005 Sep 01; 23(25):5973-82. PubMed ID: 16087950
    [Abstract] [Full Text] [Related]

  • 19. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.
    J Clin Oncol; 2006 Feb 20; 24(6):872-7. PubMed ID: 16484696
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.